ArticleCancers2025

Hepatic Arterial Infusion Chemotherapy with Serplulimab and the Bevacizumab Biosimilar HLX04 for Advanced Hepatocellular Carcinoma: A Prospective, Observational Phase II Clinical Trial.

Huikai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.